Literature DB >> 25453204

[Management of placenta previa and accreta].

G Kayem1, H Keita2.   

Abstract

OBJECTIVE: Produce recommendations for the management of placenta previa and placenta accrete.
METHODS: A literature search was conducted using Medline and the Cochrane Library over a period from 1950 to 31/12/2013. Recommendations of the latest scientific societies have also been consulted.
RESULTS: In cases of placenta previa, if bleeding episode before 34weeks gestation occurs, a short hospitalization and tocolysis may help stop bleeding (grade C). Vaginal delivery is preferable when the distance between the internal cervical os and the placental edge is greater than 20mm. When this distance is less than 20mm, vaginal delivery is possible (professional consensus). Caesarean section is recommended in cases of placenta overlapping the internal os (professional consensus). Antenatal screening placenta accreta could improve care (EL3). Upon discovery of a placenta accreta during childbirth, it is better to avoid a forced removal of the placenta (grade C). Conservative treatment or cesarean hysterectomy are possible (grade C). The management of placental abnormalities should be planned and managed with a multidisciplinary team (professional consensus). The use of blood-saving techniques such as "cell saver" is possible in situations where early intraoperative bleeding would be>1500mL (grade C). There are no studies that have sufficient methodological value to recommend an anesthetic technique [general anaesthesia (GA) or neuraxial anaesthesia] over another in the context of placental abnormalities (grade B). When a major bleeding risk is identified, GA can be chosen in order to avoid emergency conversions in difficult conditions (professional consensus).
CONCLUSION: Placental insertion abnormalities require anesthetic and obstetric coordination. Delivery must be planned in a suitable structure.
Copyright © 2014. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Anesthetic technique; Cell saver; Conservative treatment; Hysterectomy; Hystérectomie; Hémorragie du post-partum; Hémorragie massive; Massive hemorrhage; Multidisciplinary; Placenta accreta; Placenta accrete; Placenta praevia; Placenta previa; Pluridisciplinarité; Postpartum hemorrhage; Technique anesthésique; Traitement conservateur; « Cell saver »

Mesh:

Year:  2014        PMID: 25453204     DOI: 10.1016/j.jgyn.2014.10.007

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  5 in total

1.  Placenta Accreta and Total Placenta Previa in the 19th Week of Pregnancy.

Authors:  S Findeklee; S D Costa
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-08       Impact factor: 2.915

2.  Maintenance nifedipine therapy for preterm symptomatic placenta previa: A randomized, multicenter, double-blind, placebo-controlled trial.

Authors:  Eric Verspyck; Claire de Vienne; Charles Muszynski; Michael Bubenheim; Isabella Chanavaz-Lacheray; Michel Dreyfus; Philippe Deruelle; Jacques Benichou
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

3.  Feed-forward Control Nursing Model in Expectant Treatment of Placenta Previa.

Authors:  Yanfei Zhu; Shuxuan Zhang; Wenxian Shan; Ming Hu
Journal:  Iran J Public Health       Date:  2017-02       Impact factor: 1.429

4.  Differential Diagnosis of Cesarean Scar Pregnancies and Other Pregnancies Implanted in the Lower Uterus by Ultrasound Parameters.

Authors:  Kangning Li; Qing Dai
Journal:  Biomed Res Int       Date:  2020-11-24       Impact factor: 3.411

5.  Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa.

Authors:  Na Wang; Dandan Shi; Na Li; Hongyuan Qi
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.